Estrogenic Activity none
Progestational Activity no data available
Androisoxazol is an oral anabolic steroid derived from dihydrotestosterone. It is similar in structure to stanozolol, which carries a 2,3-pyrazole group instead of the 2,3-isoxazole modification used here. Danazol is another
commercial 2,3-isoxazole, although this particular agent has minimal anabolic activity. Similar to stanozolol, androisoxazol is non-estrogenic, and displays a highly
favorable balance of anabolic to androgenic effect.
Depending upon the source, it is identified as having an anabolic to androgenic ratio ranging from 7:1, all the way up to 40:1. Although no longer available, this agent possesses strong muscle building and performance enhancing properties which are accompanied by a low inclination for androgenic side effects. Being a non- estrogenic agent, androisoxazol is well suited for lean mass gains, cutting purposes, and competitive athletics.